|Articles|July 28, 2015
Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients
Author(s)Janet Freeman-Daily
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.
Advertisement
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Why Is Lung Health Key to Survivorship After Cancer Treatment?
2
U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
The Power of Personalized Care in Breast Cancer Treatment
5